Affidea CMO message on World Cancer Day 2021

Today is World Cancer Day and we take this opportunity to raise awareness and highlight the importance of screening, early stage cancer detection and treatment which can significantly improve cancer patients’ chances of survival.

On this day, I would like to thank all our medical staff for their commitment in cancer care, for their dedication in providing every day best medical care, with professionalism and empathy for every patient.

This World Cancer Day’s theme is “I am and I will”, and it comes to remind us of the enduring power of collective action, showing that our commitment to act will lead to powerful progress for a cancer-free world.

10 million people worldwide die each year from cancer. That’s more than HIV/AIDS, malaria and tuberculosis combined. By 2030, experts project cancer deaths to rise to 13 million, according to World Health Organisation.

But today, we know more about cancer than ever before. Continuous investment in innovation and the extraordinary breakthroughs in diagnostics and cancer treatment allow us to improve clinical outcomes and save millions of lives every year.

At Affidea, we envision a world where cancer is no longer a disease that cannot be cured. With clinical excellence at the core of everything we do, at Affidea, we always invest in cutting edge technology that can help our doctors treat patients with higher precision, increased safety and a more comfortable experience.

Innovation is one of our fundamental pillars to make together a healthier world and we use it to reinforce our commitment to cancer care in the countries where we operate. We have recently witnessed a great initiative from Affidea Poland to introduce new treatment techniques as hyperthermia to beat cancer. At the same time, in the summer of last year, we have installed two new True Beam linear accelerators in our Center of Excellence Banja Luka, Bosnia. The revolutionary radiotherapy and radiosurgery equipment delivers tailor-made, precise and fast cancer treatments for a wide range of complex oncological cases.

At Affidea, we are best positioned, benefitting from our wide network of center across 15 countries, working with the best medical professionals, equipped with the latest innovations and cutting edge technology, to improve cancer management and save millions of lives.

Dr Alessandro Roncacci
Senior Vice President
Chief Medical Officer Affidea